Ausgabe 6/2022
Inhalt (8 Artikel)
Review
Current Status of PSMA-Targeted Radioligand Therapy in the Era of Radiopharmaceutical Therapy Acquiring Marketing Authorization
So Won Oh, Minseok Suh, Gi Jeong Cheon
Original Article
Preliminary Study for Quantitative Assessment of Sacroiliitis Activity Using Bone SPECT/CT: Comparison of Diagnostic Performance of Quantitative Parameters
Koeun Lee, Hyunji Kim, Yong-il Kim, Bumwoo Park, Woo Hyun Shim, Jungsu S. Oh, Seokchan Hong, Yong-Gil Kim, Jin-Sook Ryu
Original Article
The Radiation Dose Absorbed by Healthy Parenchyma Is a Predictor for the Rate of Contralateral Hypertrophy After Unilobar Radioembolization of the Right Liver
Nazim Coskun, Aslihan Yildirim, Alptug Ozer Yuksel, Murat Canyigit, Elif Ozdemir
Original Article
Association of Fluorodeoxyglucose Positron Emission Tomography Radiomics Features with Clinicopathological Factors and Prognosis in Lung Squamous Cell Cancer
Mustafa Erol, Hasan Önner, İlknur Küçükosmanoğlu
Original Article
Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
Raviteja Nanabala, Maroor Raghavan Ambikalmajan Pillai, Buvaneswari Gopal
Case Report
Neuroendocrine Tumor of Tailgut Cyst with Unexpected Metastases
Gulhan Ipek Deniz, Resit Akyel, Elife Akgun, Orhun Cıg Taskın, Yersu Kapran
Interesting image
Extramedullary Hematopoiesis Visualized on FDG-PET/CT in a Patient with Beta-Thalassemia
Sara E. Dahlsgaard-Wallenius, Karen Juul-Jensen, Anne Lerberg Nielsen, Malene Grubbe Hildebrandt